News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
848,085 Results
Type
Article (86548)
Company Profile (702)
Press Release (760835)
Multimedia
Podcasts (132)
Webinars (14)
Section
Business (232710)
Career Advice (4128)
Deals (39726)
Drug Delivery (129)
Drug Development (90994)
Employer Resources (198)
FDA (18117)
Job Trends (17342)
News (396516)
Policy (39758)
Tag
Academia (3001)
Academic (2)
Accelerated approval (7)
Adcomms (30)
Allergies (96)
Alliances (56849)
ALS (107)
Alzheimer's disease (1511)
Antibody-drug conjugate (ADC) (166)
Approvals (18072)
Artificial intelligence (340)
Autoimmune disease (30)
Automation (17)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (88)
Brain cancer (32)
Breast cancer (321)
Cancer (2534)
Cardiovascular disease (213)
Career advice (3535)
Career pathing (34)
CAR-T (184)
Cell therapy (517)
Cervical cancer (22)
Clinical research (73546)
Collaboration (948)
Company closure (2)
Compensation (595)
Complete response letters (30)
COVID-19 (2870)
CRISPR (50)
C-suite (279)
Cystic fibrosis (110)
Data (2450)
Decentralized trials (2)
Denatured (46)
Depression (57)
Diabetes (306)
Diagnostics (6940)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (156)
Drug pricing (136)
Drug shortages (33)
Duchenne muscular dystrophy (108)
Earnings (97303)
Editorial (47)
Employer branding (25)
Employer resources (167)
Events (130410)
Executive appointments (802)
FDA (19592)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (851)
Gene editing (125)
Generative AI (36)
Gene therapy (381)
GLP-1 (870)
Government (5180)
Grass and pollen (6)
Guidances (174)
Healthcare (20894)
Huntington's disease (26)
IgA nephropathy (32)
Immunology and inflammation (158)
Indications (30)
Infectious disease (3035)
Inflammatory bowel disease (159)
Inflation Reduction Act (12)
Influenza (59)
Intellectual property (104)
Interviews (813)
IPO (17843)
IRA (51)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (47)
Layoffs (569)
Leadership (24)
Legal (10116)
Liver cancer (82)
Lung cancer (355)
Lymphoma (169)
Machine learning (9)
Management (65)
Manufacturing (382)
MASH (87)
Medical device (14651)
Medtech (14656)
Mergers & acquisitions (22467)
Metabolic disorders (826)
Multiple sclerosis (92)
NASH (23)
Neurodegenerative disease (124)
Neuropsychiatric disorders (36)
Neuroscience (2156)
NextGen: Class of 2025 (7682)
Non-profit (5083)
Now hiring (42)
Obesity (441)
Opinion (276)
Ovarian cancer (85)
Pain (105)
Pancreatic cancer (91)
Parkinson's disease (170)
Partnered (25)
Patents (266)
Patient recruitment (123)
Peanut (51)
People (65375)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22703)
Phase II (31941)
Phase III (24046)
Pipeline (1506)
Policy (184)
Postmarket research (3552)
Preclinical (10253)
Press Release (72)
Prostate cancer (115)
Psychedelics (38)
Radiopharmaceuticals (271)
Rare diseases (444)
Real estate (7393)
Recruiting (75)
Regulatory (26855)
Reports (59)
Research institute (2659)
Resumes & cover letters (649)
Rett syndrome (6)
RNA editing (6)
RSV (50)
Schizophrenia (84)
Series A (148)
Series B (98)
Service/supplier (30)
Sickle cell disease (61)
Special edition (20)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4295)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (59)
The Weekly (84)
Vaccines (828)
Venture capitalists (45)
Weight loss (308)
Women's health (41)
Worklife (20)
Date
Today (228)
Last 7 days (985)
Last 30 days (3754)
Last 365 days (35575)
2025 (13624)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (62)
Alaska (7)
Arizona (271)
Arkansas (14)
Asia (50191)
Australia (8843)
California (6878)
Canada (2146)
China (584)
Colorado (298)
Connecticut (313)
Delaware (171)
Europe (115230)
Florida (1004)
Georgia (234)
Hawaii (1)
Idaho (64)
Illinois (651)
India (31)
Indiana (349)
Iowa (12)
Japan (183)
Kansas (114)
Kentucky (28)
Louisiana (15)
Maine (72)
Maryland (1007)
Massachusetts (5242)
Michigan (256)
Minnesota (439)
Mississippi (2)
Missouri (93)
Montana (31)
Nebraska (26)
Nevada (72)
New Hampshire (70)
New Jersey (1917)
New Mexico (31)
New York (1923)
North Carolina (1166)
North Dakota (9)
Northern California (2974)
Ohio (229)
Oklahoma (15)
Oregon (48)
Pennsylvania (1496)
Puerto Rico (14)
Rhode Island (36)
South America (1653)
South Carolina (28)
South Dakota (1)
Southern California (2544)
Tennessee (111)
Texas (1033)
United States (26146)
Utah (202)
Virginia (182)
Washington D.C. (72)
Washington State (630)
West Virginia (3)
Wisconsin (74)
There are 848,085 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
After FDA Cuts, Planning for Upcoming ODAC Meeting Has Been ‘Absolute Chaos’
As the FDA prepares for a busy Oncologic Drugs Advisory Committee next week, an agency insider told
BioSpace
that volunteers with little training are scrambling to secure the required expertise after workforce cuts decimated the adcomm planning office.
May 15, 2025
·
4 min read
·
Heather McKenzie
Deals
Bluebird’s Private Equity Buyout Boosts Upfront Cash for Shareholders
After warnings that the dragged-out process was putting the cell therapy company at risk of bankruptcy, bluebird bio now has a new deal to offer shareholders.
May 15, 2025
·
1 min read
Press Releases
GRI Bio Reports First Quarter 2025 Financial Results and Confirms GRI-0621 Phase 2a IPF Trial on Track for 6-Week Interim Data in Q2 2025 and Topline Data in Q3 2025
May 15, 2025
·
9 min read
Press Releases
CytoDyn Releases ESMO Breast Cancer Meeting Poster
May 15, 2025
·
1 min read
Press Releases
Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
May 15, 2025
·
9 min read
Press Releases
Excision BioTherapeutics Announces Publication Highlighting EBT-107 for the Treatment of Chronic Hepatitis B in bioRxiv
May 15, 2025
·
3 min read
Press Releases
CorMedix Inc. to Participate in the RBC Global Healthcare Conference
May 15, 2025
·
1 min read
Press Releases
Autonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform Technology
May 15, 2025
·
5 min read
Press Releases
Nanalysis Announces First Quarter 2025 Conference Call
May 15, 2025
·
4 min read
Press Releases
Alpha Cognition Inc. Reports First Quarter 2025 Financial Results and Operating Overview
May 15, 2025
·
9 min read
1 of 84,809
Next
